NEW YORK (GenomeWeb) – The UK government said today that it has formed a strategic partnership with four pharmaceutical firms and a charity to provide £200 million ($247 million) to support sequencing the genomes of hundreds of thousands of participants in the UK Biobank.
The project aims to improve health through genetic research and to advance the prevention, diagnosis, and treatment of a variety of illnesses, including cancer, heart disease, diabetes, arthritis, dementia, and chronic kidney disease.
{iframe}https://www.genomeweb.com/sequencing/uk-biobank-whole-genome-sequencing-project-obtains-200m-pharma-government-philanthropy?_lrsc=9a88a207-1b9c-4988-a7f2-603e487c93ef#.XYjmNJNKhSM{/iframe}